Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Regulation of human 3 alpha-hydroxysteroid dehydrogenase (AKR1C4) expression by the liver X receptor alpha.

Stayrook KR, Rogers PM, Savkur RS, Wang Y, Su C, Varga G, Bu X, Wei T, Nagpal S, Liu XS, Burris TP.

Mol Pharmacol. 2008 Feb;73(2):607-12. Epub 2007 Nov 16.

PMID:
18024509
2.

Investigational PPAR-gamma agonists for the treatment of Type 2 diabetes.

Savkur RS, Miller AR.

Expert Opin Investig Drugs. 2006 Jul;15(7):763-78. Review.

PMID:
16787140
3.

Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators.

Ma Y, Khalifa B, Yee YK, Lu J, Memezawa A, Savkur RS, Yamamoto Y, Chintalacharuvu SR, Yamaoka K, Stayrook KR, Bramlett KS, Zeng QQ, Chandrasekhar S, Yu XP, Linebarger JH, Iturria SJ, Burris TP, Kato S, Chin WW, Nagpal S.

J Clin Invest. 2006 Apr;116(4):892-904. Epub 2006 Mar 9.

4.

Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.

Ho TH, Savkur RS, Poulos MG, Mancini MA, Swanson MS, Cooper TA.

J Cell Sci. 2005 Jul 1;118(Pt 13):2923-33. Epub 2005 Jun 16.

5.

Coactivation of the human vitamin D receptor by the peroxisome proliferator-activated receptor gamma coactivator-1 alpha.

Savkur RS, Bramlett KS, Stayrook KR, Nagpal S, Burris TP.

Mol Pharmacol. 2005 Aug;68(2):511-7. Epub 2005 May 20.

PMID:
15908514
6.

Regulation of pyruvate dehydrogenase kinase expression by the farnesoid X receptor.

Savkur RS, Bramlett KS, Michael LF, Burris TP.

Biochem Biophys Res Commun. 2005 Apr 1;329(1):391-6.

PMID:
15721319
7.

Regulation of carbohydrate metabolism by the farnesoid X receptor.

Stayrook KR, Bramlett KS, Savkur RS, Ficorilli J, Cook T, Christe ME, Michael LF, Burris TP.

Endocrinology. 2005 Mar;146(3):984-91. Epub 2004 Nov 24.

PMID:
15564327
8.

Ligand-dependent coactivation of the human bile acid receptor FXR by the peroxisome proliferator-activated receptor gamma coactivator-1alpha.

Savkur RS, Thomas JS, Bramlett KS, Gao Y, Michael LF, Burris TP.

J Pharmacol Exp Ther. 2005 Jan;312(1):170-8. Epub 2004 Aug 25.

PMID:
15329387
9.

Pharmacology of nuclear receptor-coregulator recognition.

Savkur RS, Bramlett KS, Clawson D, Burris TP.

Vitam Horm. 2004;68:145-83. Review.

PMID:
15193454
10.

Insulin receptor splicing alteration in myotonic dystrophy type 2.

Savkur RS, Philips AV, Cooper TA, Dalton JC, Moseley ML, Ranum LP, Day JW.

Am J Hum Genet. 2004 Jun;74(6):1309-13. Epub 2004 Apr 26.

11.

The coactivator LXXLL nuclear receptor recognition motif.

Savkur RS, Burris TP.

J Pept Res. 2004 Mar;63(3):207-12. Review.

PMID:
15049832
12.

Alternative splicing within the ligand binding domain of the human constitutive androstane receptor.

Savkur RS, Wu Y, Bramlett KS, Wang M, Yao S, Perkins D, Totten M, Searfoss G 3rd, Ryan TP, Su EW, Burris TP.

Mol Genet Metab. 2003 Sep-Oct;80(1-2):216-26.

PMID:
14567971
13.

Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing.

Charlet-B N, Savkur RS, Singh G, Philips AV, Grice EA, Cooper TA.

Mol Cell. 2002 Jul;10(1):45-53.

14.
15.

Preferential cleavage in pre-ribosomal RNA byprotein B23 endoribonuclease.

Savkur RS, Olson MO.

Nucleic Acids Res. 1998 Oct 1;26(19):4508-15.

Supplemental Content

Loading ...
Support Center